triazoles has been researched along with tacrolimus in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.64) | 18.2507 |
2000's | 19 (31.15) | 29.6817 |
2010's | 34 (55.74) | 24.3611 |
2020's | 7 (11.48) | 2.80 |
Authors | Studies |
---|---|
Campo, JV; Perel, JM; Smith, C | 1 |
Gayowski, T; Singh, N; Venkataramanan, R; Zang, S | 1 |
Garton, T | 1 |
Allen, S; Pai, MP | 1 |
Blankenship, JR; Heitman, J; Onyewu, C; Perfect, JR; Schell, WA; Steinbach, WJ | 1 |
Benjamin, DK; Heitman, J; Miller, JL; Perfect, JR; Schell, WA; Singh, N; Steinbach, WJ | 1 |
Cuvelier, C; Goffin, E; Kirch, L; Pochet, JM; Tintillier, M | 1 |
Claes, K; Evenepoel, P; Kuypers, DR; Vanrenterghem, Y | 1 |
Fukuoka, N; Houchi, H; Ishida, T; Kawazoe, H; Ohnishi, H; Takiguchi, Y; Tanaka, H | 1 |
Gelone, S; Kantesaria, B; Krishna, G; Mant, TG; Martinho, M; Sansone-Parsons, A | 1 |
Book, BK; Lemonte, A; Pescovitz, MD; Smedema, M; Wheat, LJ; Zhuang, D | 1 |
Andrew, S; Fitzgerald, D; Singh, MN | 1 |
Amrein, C; Bergé, MM; Billaud, EM; Boussaud, V; Chevalier, P; Daudet, N; Guillemain, R; Le Beller, C; Lillo-Le Louet, A | 1 |
Mircus, G; Osherov, N; Shadkchan, Y; Shalit, I | 1 |
Cleveland, KO; Lacasse, A | 1 |
Aisa, Y; Ikeda, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S | 1 |
Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH | 1 |
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
Dannaoui, E; Lortholary, O; Schwarz, P | 1 |
Chang, CM; Chang, HH; Ko, WC; Lee, HC; Lee, NY; Wu, CJ; Yang, YH | 1 |
Allenet, B; Auzéric, M; Bedouch, P; Bellemère, J; Charpiat, B; Conort, O; Juste, M; Rose, FX; Roubille, R | 1 |
Mehta, J; Pi, J; Scheetz, MH; Trifilio, SM | 1 |
Alangaden, GJ; Chandrasekar, PH; Manavathu, E; Narreddy, S; Revankar, SG | 1 |
Begué, D; Billaud, E; Boussaud, V; Caruba, T; Guillemain, R; Korb, V; Prognon, P; Sabatier, B; Thomas, A | 1 |
Basile, V; Capone, D; Ciotola, A; D'Alessandro, V; Federico, S; Gentile, A; Nappi, R; Polichetti, G; Renda, A; Sabbatini, M; Santangelo, M; Tarantino, G | 1 |
Kato, J; Mori, T; Okamoto, S; Ono, Y; Shimizu, T; Yamane, A | 1 |
Hatta, Y; Inoue, Y; Kato, M; Miura, I; Ogawa, K; Saito, T; Shibuya, Y; Suzuki, Y; Takahashi, M; Takeuchi, J; Takimoto, M | 1 |
Fujieda, A; Iwamoto, T; Katayama, N; Monma, F; Nakatani, K; Okuda, M | 1 |
Afshari, NA; Goldhagen, BE; Majka, CP; Perfect, JR; Rebong, RA; Santaella, RM; Steinbach, WJ | 1 |
Goto, R; Haga, S; Hirokata, G; Igarashi, R; Oura, T; Ozaki, M; Shibasaki, S; Shibata, T; Todo, S; Wakayama, K; Yamashita, K | 1 |
Mada, SR; Pillai, VC; Strom, S; Venkataramanan, R; Zhang, S | 1 |
Guinovart, JJ; Murguia, JR; Rodriguez-Hernandez, CJ | 1 |
Kato, J; Kikuchi, T; Kohashi, S; Mori, T; Okamoto, S; Ono, Y; Sakurai, M; Yamane, A | 1 |
Campo, M; Chaftari, AM; Hachem, RY; Jiang, Y; Kassis, C; Prince, RA; Raad, II; Ramos, E; Wang, W | 1 |
Debaveye, Y; Grootaert, V; Meyfroidt, G; Spriet, I; Willems, L | 1 |
Aomori, T; Araki, T; Fujita, Y; Hiromura, K; Nakamura, T; Nojima, Y; Okada, Y; Shimizu, R; Tomizawa, T; Yamamoto, K | 1 |
Ameye, L; Aoun, M; Bourguignon, AM; Bron, D; Cotton, F; Csergö, M; Hites, M; Jacobs, F; Rasson, C; Vaes, M | 1 |
Albert, N; Ben-Ami, R; Best, L; Kontoyiannis, DP; Lewis, RE; Walsh, TJ | 1 |
Dufty, NE; Else, LJ; Gilleran, G; Hawkins, D; Taylor, S | 1 |
Averette, AF; Chen, YL; Heitman, J; Lehman, VN; Perfect, JR | 1 |
McNeil, C | 1 |
Kontoyiannis, DP; Shirazi, F | 1 |
Fothergill, A; Kwon-Chung, KJ; McKew, JC; Park, YD; Shinn, P; Southall, N; Sugui, JA; Sun, W; Williamson, PR; Zheng, W | 1 |
Chen, H; Chen, SR; Hu, YM; Pan, HL | 1 |
Fung, HC; Peksa, GD; Schultz, K | 1 |
Ganetsky, A; Hughes, ME; Miano, TA; Porter, DL; Reshef, R; Vonderheide, RH | 1 |
Chung, BH; Jin, L; Lim, SW; Piao, SG; Yang, CW | 1 |
Azzopardi, M; Chambers, D; Chau, C; Hopkins, P; Robinson, CL; Yerkovich, ST | 1 |
Akhtar, S; Desai, A; Groll, AH; Han, D; Howieson, C; Kato, K; Kowalski, D; Lademacher, C; Lewis, W; Mandarino, D; Pearlman, H; Townsend, R; Yamazaki, T | 1 |
Annaert, P; Bouwsma, H; Hilbrands, L; Kuypers, DRJ; Spriet, I; Swen, JJ; Vanaudenaerde, B; Vanhove, T; Verleden, G; Vos, R | 1 |
Clancy, CJ; Ensor, CR; Falcione, BA; Nguyen, MH; Rivosecchi, RM; Shields, RK; Shullo, MA; Venkataramanan, R | 1 |
Gao, L; He, C; Li, M; Sun, Y; Zeng, T | 1 |
Alexander, MD; Armistead, PM; Daniels, LM; Kufel, WD; Ptachcinski, JR; Shaw, JR | 1 |
Dadwal, S; Jhangiani, K; Kieu, V; Nakamura, R; Pon, D | 1 |
Collins, J; Lee, P; Parsad, S; Plach, K; Shea, K | 1 |
Dannaoui, E; Felske-Zech, H; Schwarz, P; Schwarz, PV | 1 |
Aguado, JM; Andrés, A; Caravaca-Fontán, F; Fernández-Ruiz, M; Gutiérrez, E; López-Medrano, F; Morales, E; Praga, M; Sevillano, Á; Trujillo, H | 1 |
Bubalo, JS; Gu, TM; Le, H; Lewis, JS | 1 |
Aguado, JM; Bodro, M; Carratalà, J; Cordero, E; Fariñas, MDC; Fernández-Ruiz, M; Fortún, J; Goikoetxea, J; Gutiérrez Martín, I; Illaro, A; López-Viñau, T; Moreno, A; Muñoz, P; Ramos-Martínez, A; Rodriguez-Álvarez, R; Ruiz-Ruigómez, M; Sabé, N; Salto-Alejandre, S; Valerio, M; Vidal, E | 1 |
Hall, R; Kincaide, E; Levine, D; Sweiss, H | 1 |
Caracena-López, S; Fructuoso-González, L; Manresa-Ramón, N; Najera-Perez, MD; Pacheco-López, P; Torrano-Belmonte, P | 1 |
2 review(s) available for triazoles and tacrolimus
Article | Year |
---|---|
Trichosporon mucoides fungemia in a liver transplant recipient: case report and review.
Topics: Antifungal Agents; Enterococcus faecium; Fatal Outcome; Fungemia; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycoses; Peritonitis; Postoperative Complications; Tacrolimus; Triazoles; Trichosporon; Vancomycin; Vancomycin Resistance | 2009 |
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
Topics: Acute Kidney Injury; Administration, Inhalation; Amphotericin B; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Azithromycin; Ceftriaxone; COVID-19; Deprescriptions; Female; Glucocorticoids; Graft Rejection; Humans; Hydroxychloroquine; Hyperoxaluria, Primary; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Nitriles; Oxygen Inhalation Therapy; Prednisone; Pyridines; Renal Dialysis; SARS-CoV-2; Sputum; Tacrolimus; Tomography, X-Ray Computed; Triazoles | 2021 |
7 trial(s) available for triazoles and tacrolimus
Article | Year |
---|---|
Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes.
Topics: Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Humans; Immunosuppressive Agents; In Vitro Techniques; Kinetics; Liver Transplantation; Microsomes, Liver; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2002 |
Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.
Topics: Adult; Antifungal Agents; Area Under Curve; Cross-Over Studies; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Tacrolimus; Triazoles | 2007 |
Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring.
Topics: Adult; Antifungal Agents; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Triazoles; Voriconazole | 2010 |
Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation.
Topics: Administration, Oral; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Leukemia; Lipids; Lymphoma; Male; Middle Aged; Mycoses; Prospective Studies; Risk; Tacrolimus; Time Factors; Transplantation, Homologous; Triazoles | 2012 |
Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplastic syndrome.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Food-Drug Interactions; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Prospective Studies; Spectrophotometry, Ultraviolet; Tacrolimus; Triazoles; Young Adult | 2012 |
Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients.
Topics: Adult; Aged; Cyclohexanes; Drug Interactions; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Male; Maraviroc; Middle Aged; Prospective Studies; Tacrolimus; Transplantation, Homologous; Triazoles; Young Adult | 2015 |
Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.
Topics: Adult; Area Under Curve; Cyclosporine; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Middle Aged; Mycophenolic Acid; Nitriles; Prednisolone; Pyridines; Sirolimus; Tacrolimus; Triazoles; Young Adult | 2017 |
52 other study(ies) available for triazoles and tacrolimus
Article | Year |
---|---|
Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Paroxetine; Piperazines; Tacrolimus; Triazoles | 1998 |
Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1.
Topics: Alanine Transaminase; Antidepressive Agents, Second-Generation; Aspartate Aminotransferases; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Hepatitis C; Humans; Liver Transplantation; Male; Mixed Function Oxygenases; Piperazines; Substance-Related Disorders; Tacrolimus; Triazoles | 2002 |
Voriconazole inhibition of tacrolimus metabolism.
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Middle Aged; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2003 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.
Topics: Antifungal Agents; Aspergillus fumigatus; Calcineurin; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Drug Interactions; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Echinocandins; Humans; Immunosuppressive Agents; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2004 |
Interaction between voriconazole and tacrolimus in a kidney-transplanted patient.
Topics: Antifungal Agents; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2005 |
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient.
Topics: Aged; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Pyrimidines; Tacrolimus; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Change of the blood concentration of tacrolimus after the switch from fluconazole to voriconazole in patients receiving allogeneic hematopoietic stem cell transplantation.
Topics: Fluconazole; Humans; Immunosuppressive Agents; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Tacrolimus; Triazoles; Voriconazole | 2006 |
Effect of calcineurin inhibitors on posaconazole blood levels as measured by the MVista microbiological assay.
Topics: Antifungal Agents; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; False Positive Reactions; Graft vs Host Disease; Humans; Immunosuppressive Agents; Microbiological Techniques; Sirolimus; Tacrolimus; Triazoles | 2008 |
Solitary cutaneous nodule in an immunocompromised patient.
Topics: Alternaria; Ankle; Dermatomycoses; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Middle Aged; Pyrimidines; Retreatment; Tacrolimus; Triazoles; Voriconazole | 2007 |
Neuromuscular painful disorders: a rare side effect of voriconazole in lung transplant patients under tacrolimus.
Topics: Adolescent; Adult; Aspergillosis; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Lung Transplantation; Male; Middle Aged; Neuromuscular Diseases; Pain; Postoperative Complications; Pyrimidines; Retrospective Studies; Risk Assessment; Severity of Illness Index; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole | 2008 |
In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Fusarium; Humans; Hyphae; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Tacrolimus; Terbinafine; Triazoles; Voriconazole | 2009 |
Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adult; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Statistics, Nonparametric; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2009 |
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2009 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cyclosporine; Drug Interactions; Immunosuppressive Agents; Itraconazole; Microbial Sensitivity Tests; Mucorales; Rhizopus; Sirolimus; Tacrolimus; Thiazoles; Triazoles | 2009 |
Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.
Topics: Adult; Antifungal Agents; Cryptococcus neoformans; Drug Interactions; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Meningitis, Cryptococcal; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2010 |
[Designing a tool to describe drug interactions and adverse events for learning and clinical routine].
Topics: Antifungal Agents; Audiovisual Aids; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Education, Pharmacy, Continuing; Immunosuppressive Agents; Leukocyte Count; Pharmacists; Pyrimidines; Software; Students, Pharmacy; Tacrolimus; Triazoles; Voriconazole | 2009 |
In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.
Topics: Antifungal Agents; Calcineurin; Cyclosporine; Drug Interactions; Humans; Mucorales; Sirolimus; Tacrolimus; Triazoles | 2010 |
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Caspofungin; Cystic Fibrosis; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient.
Topics: Adult; Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Pyrimidines; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients.
Topics: Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Pyrimidines; Tacrolimus; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Highly activated oral bioavailability of tacrolimus on coadministration of oral voriconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Biological Availability; Drug Interactions; Female; Humans; Immunosuppressive Agents; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Bone Marrow Transplantation; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lansoprazole; Liver; Male; Mutation; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Biguanides; Calcineurin Inhibitors; Corneal Ulcer; Cyclosporine; Disinfectants; Drug Synergism; Eye Infections, Fungal; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prospective Studies; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2011 |
NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats.
Topics: Animals; CD28 Antigens; CD3 Complex; Dendritic Cells; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Animal; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Rats; Rats, Inbred Lew; T-Lymphocytes; Tacrolimus; Transplantation, Homologous; Triazoles | 2012 |
Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes.
Topics: Adult; Aged; Antifungal Agents; Cytochrome P-450 CYP3A; Female; Humans; Inhibitory Concentration 50; Kinetics; Male; Microsomes, Liver; Pyrimidines; Substrate Specificity; Tacrolimus; Testosterone; Triazoles; Voriconazole | 2012 |
Anti-diabetic and anti-obesity agent sodium tungstate enhances GCN pathway activation through Glc7p inhibition.
Topics: Amino Acids; Anti-Obesity Agents; Antineoplastic Agents; Drug Synergism; Food; Humans; Hypoglycemic Agents; Mutation; Protein Phosphatase 1; Protein Serine-Threonine Kinases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Tacrolimus; Triazoles; Tungsten Compounds | 2012 |
Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adult; Antifungal Agents; Biological Availability; Drug Interactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2012 |
Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2013 |
Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Itraconazole; Lupus Nephritis; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2013 |
Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Drosophila; Drug Synergism; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Tacrolimus; Treatment Outcome; Triazoles | 2013 |
Pharmacokinetic interaction of maraviroc with tacrolimus in a patient coinfected with HIV and hepatitis B virus following hepatic transplant due to hepatocellular carcinoma.
Topics: Anti-HIV Agents; Carcinoma, Hepatocellular; Cyclohexanes; Drug Interactions; Hepatitis B; HIV Infections; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Maraviroc; Middle Aged; Plasma; Tacrolimus; Treatment Outcome; Triazoles | 2013 |
Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans.
Topics: Animals; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Ergosterol; Lipopeptides; Male; Mice; Molecular Sequence Data; Mutation; Sequence Homology, Nucleic Acid; Tacrolimus; Triazoles | 2013 |
Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
Topics: Acute Disease; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunosuppressive Agents; Maraviroc; Methotrexate; Pentostatin; Peripheral Blood Stem Cell Transplantation; Pyrazines; Quality of Life; Tacrolimus; Triazoles; Vorinostat | 2013 |
The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis.
Topics: Antifungal Agents; Apoptosis; Calcineurin Inhibitors; Dose-Response Relationship, Drug; Itraconazole; Mucorales; Tacrolimus; Triazoles | 2013 |
Rapid identification of antifungal compounds against Exserohilum rostratum using high throughput drug repurposing screens.
Topics: Adenosine Triphosphate; Amphotericin B; Antifungal Agents; Ascomycota; Bithionol; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Repositioning; Floxuridine; Humans; Hyphae; Sepsis; Spores, Fungal; Tacrolimus; Triazoles | 2013 |
Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor.
Topics: Animals; Calcineurin Inhibitors; Casein Kinase II; Dichlororibofuranosylbenzimidazole; Excitatory Postsynaptic Potentials; Hyperalgesia; Male; Miniature Postsynaptic Potentials; N-Methylaspartate; Physical Stimulation; Posterior Horn Cells; Rats, Sprague-Dawley; Spinal Cord; Tacrolimus; Touch; Triazoles | 2014 |
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult | 2015 |
Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Calcineurin Inhibitors; Diet, Sodium-Restricted; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Fibrosis; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Immunosuppressive Agents; Kidney; Male; Oxidative Stress; Random Allocation; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Tacrolimus; Triazoles | 2015 |
Posaconazole in lung transplant recipients: use, tolerability, and efficacy.
Topics: Administration, Oral; Adult; Antifungal Agents; Drug Interactions; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Mycoses; Tacrolimus; Triazoles; Young Adult | 2016 |
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.
Topics: Antifungal Agents; Biomarkers; Cytochrome P-450 CYP3A; Drug Interactions; Female; Follow-Up Studies; Genotype; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Polymorphism, Single Nucleotide; Postoperative Complications; Prognosis; Retrospective Studies; Risk Factors; Tacrolimus; Triazoles; Voriconazole | 2017 |
Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients.
Topics: Adult; Aged; Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lung Transplantation; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Tacrolimus; Transplant Recipients; Triazoles; Young Adult | 2017 |
Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis.
Topics: Antifungal Agents; Biofilms; Calcineurin Inhibitors; Candida parapsilosis; Drug Synergism; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Phaeohyphomycosis; Tacrolimus; Triazoles; Voriconazole | 2017 |
Drug-Drug Interaction Between Isavuconazole and Tacrolimus: Is Empiric Dose Adjustment Necessary?
Topics: Allografts; Antifungal Agents; Drug Interactions; Drug Monitoring; Drug Tapering; Female; Humans; Immunosuppressive Agents; Middle Aged; Nitriles; Pyridines; Tacrolimus; Triazoles | 2020 |
Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study.
Topics: Adult; Aged; Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Sirolimus; Tacrolimus; Transplantation, Homologous; Triazoles; Young Adult | 2019 |
The impact of initiating posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Interactions; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Tacrolimus; Triazoles | 2020 |
In vitro interactions between isavuconazole and tacrolimus, cyclosporin A or sirolimus against Mucorales.
Topics: Antifungal Agents; Cyclosporine; Immunosuppressive Agents; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Nitriles; Pyridines; Sirolimus; Tacrolimus; Triazoles | 2019 |
Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
Topics: Antifungal Agents; Cyclosporine; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Nitriles; Pyridines; Retrospective Studies; Tacrolimus; Triazoles | 2022 |
Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice.
Topics: Adult; Antifungal Agents; Aspergillosis; Fungi; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Organ Transplantation; Retrospective Studies; Tacrolimus; Transplant Recipients; Triazoles | 2023 |
Effect of Isavuconazonium Sulfate and Posaconazole Delayed Release Tablets on Tacrolimus Dose-to-Concentration Ratios.
Topics: Antifungal Agents; Humans; Tablets; Tacrolimus; Triazoles | 2023 |
Isavuconazole-tacrolimus drug-drug interactions in HSCT patients.
Topics: Antifungal Agents; Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Tacrolimus; Triazoles | 2023 |